Bigfoot Biomedical rakes in $57m

Bigfoot Biomedical, which is focused on creating better health outcomes for people with insulin-requiring diabetes, has raised $57 million in funding.

18 March 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles